Gerda Silling
Overview
Explore the profile of Gerda Silling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orth H, Flasshove C, Berger M, Hattenhauer T, Biederbick K, Mispelbaum R, et al.
Infection
. 2023 Nov;
52(3):877-889.
PMID: 38017344
Purpose: Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been observed in immunocompromised hosts. Early monotherapy with direct-acting antivirals or monoclonal antibodies, as recommended by the international...
2.
Rolles B, Meyer R, Begemann M, Elbracht M, Jost E, Stelljes M, et al.
Blood Cancer J
. 2023 May;
13(1):73.
PMID: 37160870
No abstract available.
3.
Heinz A, Calkoen F, Derbich A, Miltner L, Seitz C, Doering M, et al.
Haematologica
. 2023 Feb;
108(8):2080-2090.
PMID: 36794500
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the scalability...
4.
Platzbecker U, Gotze K, Kiewe P, Germing U, Mayer K, Radsak M, et al.
J Clin Oncol
. 2022 Aug;
40(33):3800-3807.
PMID: 35998303
JCO Luspatercept has high clinical activity in patients with transfusion-dependent lower-risk myelodysplastic syndromes (LR-MDS) and ring sideroblasts (RS) relapsed or refractory to erythropoietin. We report long-term luspatercept safety and efficacy...
5.
Crysandt M, Soysal H, Jennes E, Holtick U, Mrotzek M, Rehnelt S, et al.
Eur J Haematol
. 2021 May;
107(3):324-332.
PMID: 34022082
Objective: ABO mismatch between donor and recipient occurs in 40% of allogeneic hematopoietic stem cell transplantations (HCT). Different strategies have been described to reduce isohemagglutinins (IHA) before HCT. We describe...
6.
Fiegle E, Crysandt M, Bouillon A, Silling G, Elbracht M, Begemann M, et al.
Leuk Res
. 2021 May;
108:106609.
PMID: 34006384
No abstract available.
7.
Steckel N, Groth C, Mikesch J, Trenschel R, Ottinger H, Kordelas L, et al.
Br J Haematol
. 2018 Feb;
180(6):840-853.
PMID: 29468631
Considering the unsatisfactory results of salvage therapies for patients with relapsed/refractory acute myeloid leukaemia (R/R-AML), their value before allogeneic haematopoietic stem cell transplantation (HSCT) remains questionable. However, direct allogeneic HSCT...
8.
9.
Averbuch D, Tridello G, Hoek J, Mikulska M, Akan H, Yanez San Segundo L, et al.
Clin Infect Dis
. 2017 Oct;
65(11):1819-1828.
PMID: 29020364
Background: This intercontinental study aimed to study gram-negative rod (GNR) resistance in hematopoietic stem cell transplantation (HSCT). Methods: GNR bacteremias occurring during 6 months post-HSCT (February 2014-May 2015) were prospectively...
10.
Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, et al.
Int J Antimicrob Agents
. 2016 Dec;
49(2):218-223.
PMID: 27989379
Invasive aspergillosis (IA) is a serious hazard to high-risk haematological patients. There are increasing reports of azole-resistant Aspergillus spp. This study assessed the epidemiology of IA and azole-resistant Aspergillus spp....